With connected data, biopharmas can shift their focus from data gathering to decision-making, leading to greater efficiency, agility, and impact. Bad KOL data is incomplete or unvalidated data ...

to seek, accept, and offer honest criticism of technical work, to acknowledge and correct errors, to be honest and realistic in stating claims or estimates based on available data, and to credit ...